Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Feb. 01, 2020	Feb. 02, 2019	Feb. 03, 2018
Cash flows from operating activities:
Net loss	$ (7,796)	$ (13,531)	$ (18,826)
Adjustments to reconcile net loss to net cash provided by operating activities:
Recognition of accumulated foreign currency translation adjustment	792
Amortization of deferred gain on sale-leaseback		(1,465)	(1,465)
Amortization of deferred debt issuance costs	139	171	270
Write-off of deferred debt issuance costs		186
Impairment of assets	889	4,579	4,095
Depreciation and amortization	24,563	28,653	31,073
Deferred taxes, net of valuation allowance			(2,363)
Stock compensation expense	1,922	2,004	1,636
Board of directors stock compensation	569	594	534
Changes in operating assets and liabilities:
Accounts receivable	(1,174)	(1,374)	4,068
Inventories	4,417	(3,505)	14,114
Prepaid expenses and other current assets	1,252	(464)	(1,110)
Other assets	1,797		60
Accounts payable	(2,655)	431	2,729
Operating leases, net	(4,254)
Deferred rent and lease incentives		(3,879)	297
Accrued expenses and other liabilities	(4,658)	3,341	(4,153)
Net cash provided by operating activities	15,803	15,741	30,959
Cash flows from investing activities:
Additions to property and equipment, net	(13,399)	(11,811)	(22,565)
Purchase of intangible asset		(1,150)
Net cash used for investing activities	(13,399)	(12,961)	(22,565)
Cash flows from financing activities:
Net borrowings (repayments) under credit facility	(2,690)	(5,334)	3,165
Proceeds from the issuance of long-term debt		15,000
Principal payments on long-term debt		(12,251)	(7,088)
Costs associated with debt issuances		(553)
Repurchase of common stock			(4,681)
Tax withholdings paid related to net share settlements of RSUs	(244)	(136)
Net cash used for financing activities	(2,934)	(3,274)	(8,604)
Net decrease in cash and cash equivalents	(530)	(494)	(210)
Cash and cash equivalents:
Beginning of period	4,868	5,362	5,572
End of period	$ 4,338	$ 4,868	$ 5,362